ClinicalTrials.gov
ClinicalTrials.gov Menu

Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan (D-First)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01464411
Recruitment Status : Unknown
Verified November 2011 by Takashi Kumagai, Kanto CML Study Group.
Recruitment status was:  Recruiting
First Posted : November 3, 2011
Last Update Posted : November 3, 2011
Sponsor:
Information provided by (Responsible Party):
Takashi Kumagai, Kanto CML Study Group